Latest News

Please note that some of these news items may take you from the UK/I website - medical information, including licensed uses & availability, may be different outside the UK/Ireland region.

December 15

Bayer plc
Making Greener Strides Towards Carbon Reduction
Staff at Bayer’s UK headquarters in Newbury have planted greener footsteps along the way to carbon reduction, thanks to an innovative Copenhagen Week of their own. » more

December 6

Bayer Schering Pharma
Bayer’s Xarelto® (Rivaroxaban) First Oral Anticoagulant to Show Significant Benefit in the Chronic Setting
Data from a Phase III trial of an oral anticoagulant in the chronic setting demonstrates that Bayer’s oral anticoagulant Xarelto reduces the risk of potentially fatal recurring venous blood clots by 82%. » more

December 3

Bayer Schering Pharma
Company Statement

Bayer Healthcare today submitted its appeal to NICE, contesting the institute’s Final Appraisal Determination (FAD) to deny patients with advanced hepatocellular carcinoma (HCC), the commonest form of primary liver cancer, NHS funding for Nexavar® (sorafenib).

» more